Robert Kramer, CFO at Emergent BioSolutions Inc. (EBS), sold 50,189 shares at $24.00 ($1.2M) on 2014-04-15, disclosed to the SEC on 2014-04-17.
Scheduled sale ($1.2M) by CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 2,500 | $60K | 4.9% |
| 2 | $24.36 | 47,689 | $1.2M | 95.1% |
| Total | $24.34 avg | 50,189 | $1.2M | 100% |
| Filing → |
| EBS | SELL | 2021-01-19 | $4.0M | — | Filing → |
| EBS | SELL | 2016-04-08 | $847K | — | Filing → |
| EBS | SELL | 2016-04-05 | $3.0M | — | Filing → |